Correlation Between Predictive Oncology and Mainz Biomed

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Predictive Oncology and Mainz Biomed at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Predictive Oncology and Mainz Biomed into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Predictive Oncology and Mainz Biomed BV, you can compare the effects of market volatilities on Predictive Oncology and Mainz Biomed and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Predictive Oncology with a short position of Mainz Biomed. Check out your portfolio center. Please also check ongoing floating volatility patterns of Predictive Oncology and Mainz Biomed.

Diversification Opportunities for Predictive Oncology and Mainz Biomed

0.75
  Correlation Coefficient

Poor diversification

The 3 months correlation between Predictive and Mainz is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Predictive Oncology and Mainz Biomed BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mainz Biomed BV and Predictive Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Predictive Oncology are associated (or correlated) with Mainz Biomed. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mainz Biomed BV has no effect on the direction of Predictive Oncology i.e., Predictive Oncology and Mainz Biomed go up and down completely randomly.

Pair Corralation between Predictive Oncology and Mainz Biomed

Given the investment horizon of 90 days Predictive Oncology is expected to under-perform the Mainz Biomed. In addition to that, Predictive Oncology is 2.55 times more volatile than Mainz Biomed BV. It trades about -0.08 of its total potential returns per unit of risk. Mainz Biomed BV is currently generating about -0.18 per unit of volatility. If you would invest  165.00  in Mainz Biomed BV on August 28, 2025 and sell it today you would lose (65.00) from holding Mainz Biomed BV or give up 39.39% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Predictive Oncology  vs.  Mainz Biomed BV

 Performance 
       Timeline  
Predictive Oncology 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Predictive Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
Mainz Biomed BV 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Mainz Biomed BV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Predictive Oncology and Mainz Biomed Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Predictive Oncology and Mainz Biomed

The main advantage of trading using opposite Predictive Oncology and Mainz Biomed positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Predictive Oncology position performs unexpectedly, Mainz Biomed can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mainz Biomed will offset losses from the drop in Mainz Biomed's long position.
The idea behind Predictive Oncology and Mainz Biomed BV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
FinTech Suite
Use AI to screen and filter profitable investment opportunities
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Money Managers
Screen money managers from public funds and ETFs managed around the world